Physician profile

John M Galla

Interventional Cardiology · Mobile, AL

NPI 1881743607

$81,521.00

in general payments reported to CMS, 2019-2025

29 companies · $1,691 in 2025

The $1,691 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$22,080.00
Food and Beverage$4,067.06
Travel and Lodging$615.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $73,619.90 2019-2024 Xarelto
Medtronic, INC. $1,953.45 2021-2025 Corevalve Evolut R, Onyx Frontier, Symplicity G3
Boston Scientific Corporation $1,259.87 2019-2025 Eluvia, Baylis Medical Company Radiofrequency Puncture Generator
Abbott Laboratories $1,248.09 2019-2024 Navitor, Jeti, Mitraclip
Philips North America LLC $1,053.58 2019-2025 Labosys, (Az7) Lasers
Medtronic Vascular, INC. $687.67 2019-2020
Edwards Lifesciences Corporation $271.54 2020-2024 Sapien 3 Ultra Resilia
Penumbra, INC. $192.22 2023-2025 Indigo System, Penumbra System
Shockwave Medical, INC $180.72 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Janssen Scientific Affairs, LLC $149.99 2023 Xarelto
Biotronik INC. $114.61 2022
Abiomed $103.05 2020-2025
Contego Medical, INC $92.33 2024
Cardiovascular Systems INC. $89.96 2019
Bard Peripheral Vascular, INC. $81.32 2025 Rotarexs 6 F X 135 Cm
Show all 28 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $67.01 2025 Camzyos
Veryan Medical Incorporated $57.49 2022
Novartis Pharmaceuticals Corporation $54.61 2022-2024
Baxter Healthcare $43.68 2023 Hillrom - Carnation Ambulatory Monitor
Boehringer Ingelheim Pharmaceuticals, INC. $39.97 2021-2023 Jardiance
Pfizer INC. $35.25 2023-2024
Kiniksa Pharmaceuticals International, Plc $21.30 2024 Arcalyst
Terumo Medical Corporation $20.28 2022
Amgen INC. $18.39 2019
Merck Sharp & Dohme LLC $16.95 2025 Verquvo
Inspiremd LTD $16.40 2025 Cguard Prime Carotid Stent System
Esperion Therapeutics, INC. $15.88 2021
Reflow Medical INC $15.49 2025

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John M Galla

$81,521.00

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $1,691 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/312089/john-m-galla

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.